Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.695
-0.028 (-1.63%)
At close: Dec 4, 2025, 4:00 PM EST
1.700
+0.010 (0.59%)
Pre-market: Dec 5, 2025, 7:09 AM EST
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $11.93 million as of December 5, 2025. Its market cap has increased by 67.05% in one year.
Market Cap
11.93M
Enterprise Value
-468.07K
1-Year Change
67.05%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has decreased from $37.12M to $11.93M, a decrease of -67.86%. That is a compound annual growth rate of -16.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 11.89M | 104.16% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | 44.72M | 45.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |